Skip to main content
Premium Trial:

Request an Annual Quote

Scott Kahn, Michael Gribskov, Phil Bourne, Edward Helton


Accelrys has promoted Scott Kahn from general manager and senior vice president of its life sciences division to CSO of worldwide operations. In this new role, Kahn will manage Accelrys’ software and IT R&D and will help guide the company’s future marketing direction.

Michael Gribskov, a senior staff scientist at the San Diego Supercomputer Center at the University of California, San Diego, has been elected president of the International Society for Computational Biology. Gribskov, who has served on the ISCB board of directors since 1999, became co-chair in 2000, and served as vice president under the most recent ISCB president, Phil Bourne. Gribskov’s term as president will expire in 2005.

Edward Helton, chief strategist of regulatory and biomedical affairs at Cary, NC-based SAS, has been elected to a three-year term on the board of directors for the Clinical Data Interchange Standards Consortium (CDISC).

Filed under

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.